October 6, 2023 07:30 AM EDTUpdated 04:08 PM
People
Deals

Ab­cam lays out de­tails be­hind $5.7B Dana­her ac­qui­si­tion, takeover at­tempts by founder and for­mer CEO

Katherine Lewin

News Reporter

UK-based Ab­cam re­vealed more de­tails be­hind its $5.7 bil­lion ac­qui­si­tion by Dana­her, in­clud­ing the dozens of po­ten­tial buy­ers the com­pa­ny en­gaged …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Keros halts parts of Phase 2 PAH tri­al due to safe­ty, stock tanks 70%

The brain is Eli Lil­ly's next tar­get for its obe­si­ty meds

Cor­cept’s ALS drug fails to im­prove func­tion in Phase 2 study

Lon­za looks to de­part cap­sule and health in­gre­di­ents as it un­der­goes re­struc­ture

The End­points 100: The biotech in­dus­try braces for Trump 2.0

sponsored

The key to faster, more im­pact­ful re­search? Put pa­tients in the dri­ver’s seat

A service from the Financial Times